SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-003862
Filing Date
2020-03-13
Accepted
2020-03-13 08:11:52
Documents
108
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1596045
2 ex4-1.htm EX-4.1 19983
3 ex10-64.htm EX-10.64 102912
4 ex10-65.htm EX-10.65 101781
5 ex10-66.htm EX-10.66 97944
6 ex21-1.htm EX-21.1 11265
7 ex23-1.htm EX-23.1 3689
8 ex31-1.htm EX-31.1 17944
9 ex31-2.htm EX-31.2 17545
10 ex32-1.htm EX-32.1 8906
11 ex32-2.htm EX-32.2 7854
  Complete submission text file 0001493152-20-003862.txt   7789854

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE hrow-20191231.xml EX-101.INS 1140176
13 XBRL SCHEMA FILE hrow-20191231.xsd EX-101.SCH 88490
14 XBRL CALCULATION FILE hrow-20191231_cal.xml EX-101.CAL 104545
15 XBRL DEFINITION FILE hrow-20191231_def.xml EX-101.DEF 400105
16 XBRL LABEL FILE hrow-20191231_lab.xml EX-101.LAB 613693
17 XBRL PRESENTATION FILE hrow-20191231_pre.xml EX-101.PRE 498277
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35814 | Film No.: 20710765
SIC: 2834 Pharmaceutical Preparations